No Picture
Nasdaq:OPNTUS6837501039

Opiant Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 12, 2020

SANTA MONICA, Calif., Oct. 27, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its third quarter… […]

No Picture
News

Gemelli Biotech Launches Novel Breath Test Measuring Hydrogen, Methane and Hydrogen Sulfide

LOS ANGELES & RALEIGH, N.C.–(BUSINESS WIRE)– #H2S–Los Angeles- and Raleigh-based Gemelli Biotech announced the launch of a novel breath test called trio-smart™ that provides a more complete fermented gas profile of a patient’s microbiome by meas… […]

No Picture
News

Twist Bioscience Collaborates With Beyond Earth to Launch Artwork Stored in DNA Into Space

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #DNA–Twist Bioscience Corporation (Nasdaq: TWST) and Beyond Earth, an artist collective, today announced a project to store high-resolution artworks in DNA to be launched to low Earth orbit and the Moon. … […]

No Picture
News

TAE Life Sciences and CNAO (National Center of Oncological Hadrontherapy) Announce a Research and Clinical Collaboration for the Implementation of a New Facility with Boron Neutron Capture Therapy System in Italy

FOOTHILL RANCH, Calif.–(BUSINESS WIRE)–TAE Life Sciences today announced that it has entered into an agreement with National Center of Oncological Hadrontherapy (CNAO). […]

No Picture
Nasdaq:ARQTUS03969K1088

Arcutis Completes Enrollment in Phase 1/2b Study Evaluating ARQ-252 in Chronic Hand Eczema

WESTLAKE VILLAGE, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a medical dermatology company developing innovative treatments for patients with immune-mediated dermatological diseases and conditions, today a… […]

No Picture
News

Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial

LOS ANGELES–(BUSINESS WIRE)– #Amgen–Global Coalition for Adaptive Research (LOS ANGELES, CA), Amgen (THOUSAND OAKS, CA), and Eisai Co., Ltd. (TOKYO, Japan “Eisai”) — The Global Coalition for Adaptive Research (GCAR) in collaboration with Amgen and … […]

No Picture
News

EpicGenetics Announces Research Activity with Mayo Clinic to Advance Fibromyalgia Diagnostics

LOS ANGELES–(BUSINESS WIRE)–EpicGenetics announced a contract with the Mayo Clinic Fibromyalgia and Chronic Fatigue Clinic to perform research to investigate the use of the EpicGenetics FM/a® Test to determine the test’s use and applicability to obje… […]

No Picture
News

News briefing: AstraZeneca follows Amgen down KRAS/SHP2 combo path; Vallon Pharmaceuticals files for $17 million IPO 

Revolution Medicines is adding AstraZeneca to its roster of clinical collaborators, lending its lead drug, RMC-4630, for a study pairing it with the pharma giant’s KRAS G12C program.
AstraZeneca will sponsor and conduct the study once its now preclinic… […]